What is the recommended treatment for central nystagmus?

Treatment for Central Nystagmus

The treatment of central nystagmus requires immediate MRI neuroimaging to identify structural lesions, followed by targeted pharmacotherapy based on the specific nystagmus subtype: 4-aminopyridine for downbeat and upbeat nystagmus, baclofen for periodic alternating nystagmus, and gabapentin or memantine for pendular fixation nystagmus. 1, 2, 3

Immediate Diagnostic Workup

• MRI of the brain with dedicated posterior fossa sequences must be performed in all patients with suspected central nystagmus to detect stroke, tumor, demyelination, or cerebellar degeneration. 1
• Neuroimaging should not be delayed; early identification of structural lesions is essential before attributing symptoms to benign causes. 1
• If initial pharmacotherapy fails, reassess the diagnosis and evaluate for coexisting peripheral vestibular pathology. 1

Clinical Features Indicating Central Origin

Key patterns that strongly suggest central nystagmus include:

• Downbeat nystagmus without torsional component (most common central type, typically from bilateral floccular lesion or dysfunction). 1, 2, 3
• Direction-changing nystagmus that does not vary with head position. 1
• Gaze-evoked nystagmus. 1, 2
• Upbeat nystagmus (caused by midbrain or medulla oblongata lesions). 2, 3
• Periodic alternating nystagmus that reverses direction without head position changes. 1, 2, 3
• Pure torsional, pendular fixation, or seesaw nystagmus. 2, 3

Pharmacotherapy by Nystagmus Subtype

Downbeat Nystagmus

• 4-aminopyridine (4-AP): 5 mg three times daily or sustained-release fampridine 10 mg once or twice daily is the first-line treatment, supported by two randomized controlled trials showing significant improvement in nystagmus intensity, visual acuity, and postural imbalance. 3, 4, 5
• Alternative: Chlorzoxazone (evidence from one observational study). 4

Upbeat Nystagmus

• 4-aminopyridine: 5 mg three times daily or sustained-release fampridine 10 mg once or twice daily. 2, 3, 5
• Alternative: Baclofen 5-10 mg three times daily. 5

Periodic Alternating Nystagmus

• Baclofen (GABA-B receptor agonist): 5-10 mg three times daily. 2, 3, 5

Pendular Fixation Nystagmus

• Gabapentin: up to 2400 mg/day (non-selective GABAergic and anti-glutamatergic effect). 2, 3, 5
• Alternative: Memantine up to 40 mg/day (anti-glutamatergic effect). 2, 5

Special Considerations for Pediatric Patients

When assessing children with central nystagmus:

• Measure binocular distance and near visual acuity (at 40 cm and preferred reading distance) because binocular viewing permits compensatory head postures that reduce nystagmus amplitude. 6, 1
• Avoid monocular occlusion during visual testing, as it increases latent nystagmus amplitude and artificially lowers measured acuity. 6, 1
• If monocular measurement is unavoidable, use a high-plus sphere as the occluder to minimize impact on nystagmus. 6, 1
• Perform cycloplegic retinoscopy to uncover significant refractive errors that may improve visual acuity when corrected. 6, 1
• Provide prompt referral for low-vision rehabilitation services for infants, preschoolers, and school-aged children. 6

Common Pitfalls to Avoid

• Do not attribute symptoms to benign causes without neuroimaging first—structural lesions must be excluded. 1
• In children, do not measure only monocular distance acuity; binocular measurements are critical for accurate assessment. 6, 1
• All pharmacotherapy recommendations represent off-label use; patients should be informed accordingly. 5
• If the first medication fails, reconsider the diagnosis rather than simply switching agents. 1